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Summary 
During the differentiation of thymocytes to mature T  cells the processes of positive and nega- 
tive selection result in signals that either protect thymocytes from cell death, or delete, through 
apoptosis, thymocytes with  self-reactive T  cell receptors  (TCR).  Glucocorticoids have been 
shown to induce thymocyte apoptosis and are produced within the thymic microenvironment. 
Furthermore, steroid-induced apoptosis of thymocytes has been suggested as a potential mech- 
anism for removal of nonselected thymocytes. In this report, we demonstrate that thymocytes 
can be rescued  from glucocorticoid-induced  apoptosis by incubation  with  cells  that  express 
high levels of B7-1  or B7-2.  In addition,  the ability to be rescued by B7-1  and/or B7-2 can 
precede expression of the  TC1K.  We  demonstrate that  CD3+-depleted  or CD3+/TC1K-[3 +- 
doubly  depleted  thymocytes can be  rescued from glucocorticoid-induced  apoptosis through 
the interaction of CD28 or CTLA-4 on thymocytes with cells bearing high levels of B7-1  or 
B7-2.  Furthermore, these transfected cells are major histocompatibility complex (MHC)  class II 
negative and,  while they may express MHC  class I, there is no preferential rescue  of CD8 + 
thymocytes in the presence of glucocorticoids. Together, these data suggest that the rescue of 
thymocytes from glucocorticoids can be independent  of the TCR. We also demonstrate that, 
in addition to CD28, CTLA-4 is expressed on thymocytes, suggesting that rescue from gluco- 
corticoid-induced cell death can be mediated by both CD28  and CTLA-4. A  CTLA-4Ig fu- 
sion protein which binds to both B7-1 and B7-2 was shown to completely block the rescue of 
thymocytes from glucocorticoid-induced cell death.  Therefore, we conclude that interactions 
between B7-1/B7-2 and CD28/CTLA-4 are sufficient and necessary for rescue ofthymocytes 
from glucocorticoid-induced cell death. 
T 
CIK-[3 in association with pre-TC1K-e~ is expressed at 
low levels on the CD4  CD8- double negative (DN) l 
thymocyte population, and expression of this pre-TC1K in- 
creases during the progression to the CD4+CD8 + double- 
positive (DP) stage (1). TC1K-o~ genes rearrange during the 
DP stage of development, so that the thymocyte expresses a 
mature TC1K-ot/[~ together with the CD3 signaling com- 
plex (2).  CD4+8+3+TC1K-e~/[3 + thymocytes continue dif- 
ferentiating to the mature single positive  (SP)  CD4+8-3 + 
and  CD4-8+3 +  populations,  which  express  TC1K-od[3 
molecules  capable of  interacting  with  antigens  associated 
1Abbreviations used in this paper: DN, double negative; DP, double positive; 
FSC  hi  and I% greater and lower forward scatter; ORF,  open reading 
frame; SP,  single positive; TdT, terminal deoxynucleotidyl transferase; 
TUNEL, terminal deoxynucleotidyl  transferase. 
with MHC molecules. It is unclear how thymocytes progress 
through these maturational stages;  however, it is well doc- 
umented  that  approximately 95%  of the  thymocytes  die 
during  selection.  As  a potential mediator of the  observed 
cell death, it has been reported that the thymic microenvi- 
ronment produces glucocorticoids (3),  and glucocorticoids 
induce  thymocyte apoptosis  (4,  5).  Therefore,  it is a  rea- 
sonable assumption that glucocorticoids in the thymus are 
involved, at least in part, in the removal ofthymocytes that 
are not selected to survive. Moreover, it has been demon- 
strated that rescue signals  from glucocorticoid induced-cell 
death  can  be  generated  through  the  TCP,  complex  (6). 
This  would  insure  that  T  cells  that  express  a  functional 
TCR  complex may be able to survive exposure to gluco- 
corticoids. 
TCR  recognition  of  antigens  associated  with  MHC 
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response. However, for T  cells to become activated, the 
interaction of CD28  or CTLA-4 on T  cells with B7-1  or 
B7-2 expressed on APC is required (7).  TCP, engagement 
in the  absence  of costimulation results  in  anergy and/or 
death ofT cells.  CD28 is expressed on thymocytes (8),  and 
participates in thymocyte development. In one study, sub- 
stantial levels of apoptosis were detected when thymocytes 
were  incubated with  antibodies to  both  CD3  and CD28 
(9).  In another study, coligation of the anti-TCP, antibod- 
ies in combination with anti-CD28 antibodies rescued thy- 
mocytes  from  apoptotic  death  (10).  The  differences  be- 
tween  these  studies  likely  reflect  the  effects  of different 
antibodies, e.g.,  anti-CD3, anti-TCR, and anti-CD28, or 
different  maturational stages  of thymoctyes  used  in  each 
study. Nonetheless, both studies confirm that costimulatory 
molecules are involved in thymic development. 
In this report, we confirm the role of costimulatory mol- 
ecules in the thymus by demonstrating that the competence 
of thymocytes to survive glucocorticoid-induced apoptosis 
is  mediated  through  CD28/CTLA-4  interactions  with 
BT-1/B7-2.  This process  does  not require,  and may pre- 
cede, acquisition of functional TCR. 
Materials and Methods 
Transfected Cells.  The  Igk2-based  vector  VLPEk2.13  was 
constructed by inserting the VL-Vk2 intron just downstream of 
the 4.0-kb murine Vk2 promoter derived from VkCATXS (11) 
and flanked by a PmeI cloning site and a genomic segment, in- 
cluding at  the  Ck2  polyadenylation, 3'-untranslated sequences, 
and 1-kb flanking sequences.  The 1.65-kb Ek2-4 enhancer frag- 
ment derived from V~.CATXS  was inserted downstream of the 
transcriptional  unit. The promoter-cDNA-enhancer  insert can be 
released for transfection by digestion with SalI. 
Amplification of sequences  encoding the open reading frame 
(OR.F)  of murine B7-1  was accomplished  using PCR with oli- 
gonucleotides  5'-AGTACTATGGCTTGCAATTGTCAGT,  and 
5'-GTTTAAACTAAAGGAAGACGGTCTGTT,  and  plasmid 
pmB7-1  (provided by M.C.  Crooks,  University of California, 
San Diego,  CA), as template DNA.  The PCR fragment was li- 
gated into pSG5 (12) to make pSG5-B7-1.14.  The vector for ex- 
pression  of murine B7-1 in transfected  cells was made by release 
of the B7-10RF from pSG5-B7-1.14 using ScaI and PmeI and 
ligation into the PmeI site of VLPEk2.13.  Sequences  encoding 
the ORF of murine B7-2 were amplified from CH12 lymphoma 
cDNA  using PCI<  and  oligonucleotides 5'-TGTAGACGTG- 
TTCCAGAACTTACGG  and  5'-ACTGCCTTCACTCTG- 
CATTTGG and subcloned into Bluscript KS  + to make B7-2-2.5. 
The  open reading frame  was  excised  with AccI, blunted with 
Klenow fragment,  and ligated into the PmeI site of VLPEk2.13. 
J558L plasmacytoma  cells were transfected with 2 ~g SV2-gpt 
and 10 ~g of either kBT-1  or kBT-2.  Cells were electroporated 
using a GenePulser (Bio-R.ad  Laboratories,  Richmond, CA)  set 
at 280 V/960 btfd and grown in selective medium. Viable clones 
were  stained  for  expression  of B7-1  and  B7-2  using  mAbs 
(PharMingen, San Diego, CA) and analyzed by FACScan  ® (Bec- 
ton Dickinson and Co., Mountain View, CA). 
Rescue  from Glucocorticoid-mediated Cell Death.  Thymocytes  were 
harvested from either C57BL/6, AKR, or CBA/J strains of mice. 
For each experiment, 2.5 ×  106 cells were treated with dexametha- 
sone at 10 -6 M, or treated with dexamethasone in the presence of 
8  ×  10  s fixed  (1% paraformaldehyde)  B7-1- or B7-2-transfected 
J558L plasmacytoma cells, or left untreated.  After overnight incu- 
bation, the thymocytes were stained with a biotinylated anti-CD4, 
GK1.5, and a PE-conjugated anti-CD8 (PharMingen) followed 
by cychrome-conjugated streptavidin (PharMingen). Similar re- 
sults were  observed with  thymocytes from  each  of the  mouse 
strains. 
Terminal Deoxynucleotidyl Transferase (TUNEL) Assay for Apop- 
tosis Using Flow Cytometric Analysis.  After cell surface staining, thy- 
mocytes were fixed in 1.5% paraformaldehyde  and labeled with a 
fluorescein-conjugated  dUTP using TUNEL (Gibco BP,.L, Grand 
Island, NY), which labels fragmented DNA. Cells were analyzed 
by flow cytometry on a  FACScalibur  ~  (Becton Dickinson and 
Co., San Jose,  CA). Typically,  two peaks were seen in the green 
fluorescence channel (FL-1), with the more intense green fluores- 
cent peak  representing apoptotic cells. Greater than 96% of the 
transfected  cells were gated out of the analysis based on forward 
versus side scatter. B7-1 and B7-2 transfectants expressed low lev- 
els of CD4 and did not express CD8. For analysis of apoptosis in 
thymocytes,  regions were  set  on CD4+CD8 +  (DP),  CD4 +  or 
CD8 + (SP), and CD4-CD8- (DN) populations. FL-1 histograms 
of fluorescence  intensity, as a measure  of apoptosis, were gener- 
ated from each gated region. The DP population was gated, then 
additional gates for forward  versus side light scatter were applied 
to assay for live versus apoptotic cells, as reported previously (13). 
Additional experiments were performed to address the generation 
of  an  intermediate  peak  in  FL-1.  Treated  thymocytes  were 
stained with propidium iodide, which indicated that the cells are 
not cycling (data not shown). Morphological data using H6chst 
dye  and propidium iodide  suggest  that  the  cells are  apoptotic 
(data not shown). 
Depletion of CD3 + and TCR-j8 + Thymocytes.  Thymocytes  were 
incubated with an anti-CD3 mAb, 145-2C11, alone or in combi- 
nation with a  TCR-[3-specific antibody, H57-597.  Each  anti- 
body was used at 25 ~g/ml for 20 min on ice.  Cells were then 
washed  and incubated with a 1:50 dilution of baby rabbit com- 
plement (Accurate Chemical Co., Westbury, NY) at 37°C for 45 
min. After depletion, cells were counted using trypan blue exclu- 
sion to determine viable cells, followed by staining for CD3 and 
TCR-~ to verify depletion. Cells were then treated  as described 
above. 
Blockade of  Rescue  fiom Glucocorticoid-mediated  Cell Death.  B7-1  and 
B7-2  transfectants  were  incubated  with  saturating  levels  of 
CTLA-4Ig fusion protein on ice for 20 min. Transfectants  were 
then washed and immediately fixed in 1.0% paraformaldehyde  as 
before.  Both CTLA-41g treated  and untreated transfectants were 
incubated with  thymocytes in the  presence  of 10  6 m  dexa- 
methasone as  described  above.  Alternatively, thymocytes were 
pretreated with anti-CD28 (Pharmingen), or anti-CTLA-4 (pro- 
vided by  J. Allison, University of California, Berkeley, CA) at 25-50 
Ng/ml, then incubated with transfectants and dexamethasone. 
Immunofluorescent Staining of Thymocytes for CD28 and CTLA-4 
Expression.  Single  cell suspensions  of thymocytes were  stained 
with a biotin-conjugated anti-CD28 (PharMingen) followed by 
fluorescein-conjugated streptavidin  (Jackson  ImmunoResearch 
Laboratories,  West Grove, PA), or a fluorescein-conjugated  anti- 
CTLA-4 (provided  by J. Allison), and washed  three times. Thy- 
mocytes  were  then  stained  with  biotin-conjugated anti-CD4 
(GK1.5),  and PE-conjugated anti-CD8, followed by cychrome- 
conjugated streptavidin. Analysis was performed using a FACScal- 
ibur  ®  flow cytometer. The isotype control was a hamster IgG Ab. 
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Transfected Cells Expressing High  Levels of Either B7-1  or 
B7-2 Rescue Immediately Ex  Vivo Thymocytes  from  Glucocorti- 
coid-mediated Cell Death.  As  previously  described,  apop- 
totic  death  can  be  measured by the  TUNEL  assay, i.e., 
labeling the  ends  of fragmented DNA  with  FITC-dUTP 
and nonlabeled nucleotides using terminal deoxytnucleoti- 
dyl transferase (TdT)  (14). We have adapted this approach 
to quantitate cells undergoing apoptosis using flow cytome- 
try.  For  these  experiments,  immediately ex  vivo  thymo- 
cytes from various mouse strains were isolated, treated with 
dexamethasone in the presence or absence ofparaformalde- 
hyde-fixed B7-1  or B7-2 transfected cells, and incubated 
for  18  h.  The  transfected cells, which  are larger and  more 
granular  than  thyrnocytes,  were  gated  out  of the  analysis 
based  on  forward  versus  side  light  scatter.  Because  para- 
formaldehyde-fixed transfected  cells were  used,  only  cell 
contact-mediated  signals  were  provided  to  thymocytes. 
We  experimentally defined  "dead"  cells to  be  those  cells 
which  demonstrated  increased  fluorescence  from  TdT- 
mediated uptake of FITC-dUTP  after treatment with glu- 
cocorticoids.  Furthermore,  within  each  experiment  the 
dead population was defined relative to "live" cells, which 
characteristically had a lower fluorescence profile also seen 
in live, untreated thymocytes. The use of internal controls 
to establish live versus dead populations is essential because 
of interexperiment variability in labeling with TdT/FITC- 
dUTP.  In addition, the less fluorescent cells were classified 
as live by trypan blue exclusion, as well as by exclusion of 
propidium iodide, measured  cytometrically. Cells referred 
to as DP were  determined by electronically gating on  the 
thymocytes that  expressed both  CD4  and  CDS.  All other 
thymocytes were gated out of the analysis. As shown  (Fig. 
1  A),  after  overnight  culture  without  treatment  (Sham), 
gated  CD4+CDS+(DP)  thymocytes  underwent  spontane- 
ous apoptosis (ranging from 23  to 40%),  whereas immedi- 
ately  ex  vivo  thymocytes  demonstrated  <1%  apoptotic 
cells (data not shown). We demonstrate here (Fig. 1 B) that 
dexamethasone induced substantial increases in apoptosis of 
DP  thymocytes,  as  has  been  reported  (4,  15).  However, 
when  either B7-1  or B7-2 transfected cells were included, 
dexamethasone-induced  apoptosis  was  completely  inhib- 
ited (Fig. 1,  D  and E, respectively). Interaction of the thy- 
mocytes with the nontransfected parental cells (Fig. 1 C) did 
not  result in the rescue provided by cells transfected with 
either  B7-1  or  B7-2.  These  data  support  the  conclusion 
that costimulatory interactions are involved in rescue from 
cell death.  The  modest  inhibition  of apoptosis seen  with 
incubation with  the parental cells most likely results from 
the low level of endogenous expression of B7-1  and B7-2 
by these cells. 
Protection from  Glucocorticoid-induced Cell Death  Does Not 
Require Expression of TCR.  Given  the  reports  that  TCIL 
can mediate rescue ofthymocytes from glucocorticoids (8), 
we examined the question of whether costimulatory signals 
alone are sufficient to rescue thymocytes from glucocorti- 
coid-induced cell death in the  absence  of TCR  mediated 
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Figure  1.  B7-1- and B7-2-transfected cells rescue thymocytes from 
glucocorticoid-induced cell death.  Isolated thymocytes from C57BL/6 
mice were treated with dexamethasone with and without B7-1- or B7- 
2-transfected cells  for 18 h. After treatment, cells  were stained for CD4 and 
CD8. Gates  were set for CD4+8 + DP, DN, and CD4 + or CD8 + SP regions. 
TUNEL assays, TdT to label fragmented DNA of apoptotic cells with 
FITC-dUTP, were used to quantitate cell death. Analysis  was restricted 
to the gated DP region. (A) Untreated thymocytes. (B) Dexamethasone, 
10  6 M,  treated  thymocytes.  (C)  Thymocytes  treated  with  10  -6  M 
dexamethasone and paraformaldehyde-fixed,  untransfected parental  J558L 
cells (concentration of nontransfected cells:thymocytes; 1:5). (D)Thy- 
mocytes, 2  ×  106, treated with  10 -6 M dexamethasone and incubated 
overnight with B7-1 transfectants, 4  ×  105  (concentration of transfec- 
tants:thymocytes; 1:5). (E) Thymocytes treated with 10 -~ M dexametha- 
sone and B7-2-transfected cells at a 1:5 (transfeciant:thymocyte)  concen- 
tration. Percent apoptotic cells (upper fight comers of histograms), were 
determined by setting gates based on dexamethasone-induced increase in 
FL-1. Gates for the apoptotic population were set as represented by the 
dashed line. (Data shown are representative of at least three experiments.) 
signals.  We  removed  the  majority  of CD3 +  or  CD3+/ 
TCR-[3 + thymocyte populations and examined the ability 
of the  B7  transfectants  to  inhibit dexamethasone-induced 
apoptosis. Experimentally, we  used antibodies that  recog- 
nize TCR  or CD3,  together with complement, to remove 
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Percent reduction in 
Treatment  total thymocytes* 
Untreated 
Complement  0% 
anti-CD3  8% 
anti-TCR  0% 
anti-CD3 +  complement  50% 
anti-TCR +  anti-CD3 +  complement  87% 
*Observations are representative of several experiments. 
Thymocytes  were  isolated from  mouse  strains including  C57BL/6. 
Cells at a concentration  of 2  ×  106/ml were  treated with anti-CD3 
(145-2Cll) or anti-TCR (H57-597)  at 20  t*g/ml on ice for 30 min, 
followed by baby rabbit complement at a 1:50 dilution. Cells were in- 
cubated at 37 ° C for 1 h then washed three times with PBS. Cells were 
then stained with trypan blue and counted to determine the percent re- 
duction in total thymocytes. 
>50%  of thymocytes (Table  1).  Staining of cells after de- 
pletion revealed a marked loss of both CD3 + (Fig. 2 A) and 
TCR +  (Fig. 2  B)  cells. As further support that  TCR  en- 
gagement is not necessary for rescue, the transfected J558L 
cells that express B7-1  or B7-2 do not express MHC  class II 
(D.H. Wagner, unpublished result). 
The  B7  transfectants  inhibited  thymocyte  apoptosis,  as 
evidenced by loss of the apoptotic peak in TUNEL  assays, 
but  a  population with  intermediate fluorescence intensity 
was detected when B7-2 transfectants were used to inhibit 
dexamethasone induced death.  (Fig. 3,  D  and at/).  To  de- 
termine the nature of the cells in the intermediate peak, we 
set  gates  on  forward  versus  side  scatter of the  previously 
gated DP  thymocytes.  It has  recently been  reported  that 
cells with  greater forward scatter  (FSC  hi)  are  enriched for 
the live population, while those with lower forward scatter 
(FSC  1°)  are  apoptotic  (13).  This  result  is  demonstrated  in 
Fig.  3,  A  and  E.  The  gated FSC  hi populations  (solid  lines, 
Fig.  3)  of  both  CD3+-depleted  and  CD3+/TCR-13 +- 
depleted DP thymocytes were susceptible to dexamethasone- 
mediated  apoptosis, but  each  contained  a  dexamethasone 
resistant subpopulation (Fig. 3, B and F). B7-1  transfectants 
completely inhibited dexamethasone-mediated apoptosis in 
both CD3 +- and CD3+/TCR-[3+-depleted cells (Fig. 3,  C 
and  G, respectively) and furthermore,  rescued the sponta- 
neously apoptotic thymocytes (FSC  1° represented by dashed 
lines,  Fig.  3,  C  and  G),  in  the  CD3+-depleted  and  the 
CD3+/TCR.-13+-depleted  groups.  At  a  ratio  of 1:3  (tram- 
fectants:thymocytes), B7-2  transfectants  rescued  15.5%  of 
the  CD3+-depleted  cells and  20.6%  of the  CD3+/TCR - 
J3+-depleted cells from dexamethasone-mediated cell death, 
but  still  generated  an  intermediate  peak.  While  the  ap- 
proach of scatter-based electronic gating did not allow us to 
determine  the  nature  of the  intermediate peak unequivo- 
cally, possible explanations for this peak include the label- 
ing of breaks in DNA  during cell cycle (not a reflection of 
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Figure 2.  Depletion  of CD3 + and TCR + thymocytes. Whole  thy- 
mocytes were treated with biotinylated 145-2Cll  (anti-CD3e) and/or 
biotinylated H57-597 followed by baby rabbit complement as described 
in Materials and Methods. Immediately after depletion, cells were stained 
with  biotinylated  145-2Cll  and  biotinylated  H57-597  followed  by 
FITC-streptavidin. Flow cytometric analysis  was performed on a FACS- 
calibur  ®. Histograms represent (A) CD3 + depletion, and (B) TCR-J3+/ 
CD3+depletion. Dashed lines are (A) CD3  or (B) TCR expression on 
untreated thymocytes and solid lines represent expression after depletion. 
apoptotic death),  or partial degradation during early stages 
of apoptosis. 
Protection from  Glucocorticoid-mediated  Cell  Death  Can  Be 
Blocked with CTLA-4Ig.  To  demonstrate  that  the  rescue 
of thymocytes  from  glucocorticoids is  mediated  by  B7-1 
and/or B7-2,  we performed the assay in the presence of a 
CTLA-4Ig fusion  protein  (16).  CTLA-4Ig binds  to  both 
B7-1  and B7-2,  thereby blocking interaction between  the 
B7-1  and/or  B7-2  and  CD28/CTLA-4  molecules.  As 
demonstrated in earlier experiments, B7-2 transfectants res- 
cued gated, DP  thymocytes from  dexamethasone-induced 
cell death (Fig. 4  C). CTLA-4Ig binding to B7-1/B7-2  on 
transfected ceils completely blocked inhibition ofapoptosis 
(Fig. 4  D).  Pretreatment of thymocytes with control anti- 
bodies, which included TCR-13-specific (H57-597), MHC 
class I-specific antibody (34-5-8),  and MHC  class II-spe- 
cific  antibody  (MK-D6),  did  not  block  rescue  (data  not 
shown).  Taken  together,  these  data  show  that  the  signals 
for rescue ofDP  thymocytes from dexamethasone-induced 
apoptosis are provided by B7-1  or B7-2. 
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Figure 3.  Rescue of CD3 +- and TCR-[3 +- 
depleted  thymocytes  from  glucocorticoid- 
induced cell death. Total thymocytes from C57/ 
BL6  were  treated  as  follows:  (A-D)  CD3 +- 
depleted.  (E-H)  CD3+/TCR-~+-depleted.  (A 
and E)  Untreated thymocytes. (B and F)  Thy- 
mocytes treated  with  10 -6 M  dexamethasone. 
(C  and  G)  Thymocytes  treated  with  dexa- 
methasone and B7-1 transfected cells [1:3 trans- 
fectant:thymocyte].  (D  and  /t)  Thymocytes 
treated  with  dexamethasone  and  BT-2-trans- 
fected  cells  [1:3].  After  overnight  incubation, 
cells were stained for CD4/CD8 expression and 
apoptosis  levels  were  determined  using  the 
TUNEL assay read flow cytometrically. During 
analysis, gates were set for DP, DN, and CD4/ 
CD8  SP  regions.  Additional  gates  for  FSC  hi 
(most live population)  and FSC  1°  (most apop- 
totic population) were applied to the DP popu- 
lation.  Analyses of apoptosis  (increase in  FL1) 
were  performed  on  the  FSC  hi  (solid lines)  and 
FSC  l°  (dashed fines) gated  regions  of the  DP 
population. Percent apoptosis (upper right corner) 
were  determined by  gating for  apoptotic  cells 
from the FSC hi population only. (Data are rep- 
resentative of at least three experiments.) 
The  ability  of CTLA-4Ig  to  c~mpletely  block  rescue 
demonstrates  that  the  interaction  betvge~n  B7-1  or B7-2 
with  CD28/CTLA-4  on  thymocytes is  sufficient  to  pre- 
vent glucocorticoid-induced cell death.  The question arises 
as to whether B7 molecules mediate  rescue through inter- 
actions with CD28, CTLA4, or both. Pretreatment of thy- 
mocytes from the  C57BL/6  strain  with  anti-CD28  com- 
pletely blocks the rescue from glucocorticoid-mediated cell 
death  provided  by the  transfectants.  In contrast,  pretreat- 
ment of thymocytes from BALB/c with anti-CD28 blocks 
14%  of the  rescue  signal,  while  pretreatment  with  anti- 
CTLA-4 completely blocks rescue (data not shown). These 
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data suggest that C57BL/6 mice predominantly use CD28 
for thymocyte rescue from glucocorticoids, while BALB/c 
may use predominantly CTLA-4. 
While  CD28  is  constitutively  expressed  on peripheral 
T  cells and thymocytcs (8) and CTLA-4 is induced on acti- 
vated  T  cells  (17)  the  expression  of  CTLA-4  on  thy- 
mocytes  had  not  been  demonstrated.  The  expression  by 
thymocytes of both CD28 and CTLA-4 is expected if en- 
gagement of these molecules can mediate rescue from glu- 
cocorticoids. Therefore, thymocytes were triply stained for 
CD4, CD8, and CTLA-4 or CD28. Gates were set for DP, 
CD4,  CD8 SP, and DN thymocyte populations  (Fig 5, A, .0 
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Figure  4.  Blockade  of B7-1/2- 
mediated  rescue  from  glucocorti- 
coid-induced  cell  death.  Thy- 
mocytes,  2.5  ×  106, from BALB/c 
mice  were  CD3 +  depleted  as  de- 
scribed  in  Materials  and  Methods. 
Apoptosis  in  the  DP  thymocyte 
population  was  determined  by 
TUNEL assay as described in Fig. 1. 
(A)  Untreated.  (B)  Thymocytes 
treated with 10 -6 M dexamethasone. 
(C) Thymocytes treated with 10 -~ M 
dexamethasone  and  8  ×  10  S B7-2 
transfectants. (D) Thymocytes treated 
with dexamethasone  at 10 -6 M and 
8  ×  105 B7-2  transfectants,  which 
had  been pretreated  with  1 btg/ml 
CTLA-4-1g fusion protein.  Control 
antibodies  included  anti-TCR[3, 
H57-597,  anti-MHC class I (H-2d), 
34-5-8,  and  anti-MHC  class  II 
(I-Aa), MK-D6. All antibodies were 
used at 25 }xg/ml. 
B,  C,  and  D,  respectively).  CTLA-4  expression  was  dem- 
onstrated  in  both  SP  populations,  with  CD4 +  SP  having 
higher  expression  than  CD8 +  SP  cells.  CD4+CD8 +  DP 
thymocytes expressed CTLA-4, and the DN  cells expressed 
low  but  detectable  levels  as  compared  with  isotype  con- 
trois. As has been previously reported (18),  thymocytes also 
expressed  CD28  (Fig.  6).  These  results  support  our obser- 
vations  that  CD28  and  CTLA-4  may  each  participate  in 
the rescue of thymocytes from glucocorticoid-induced  cell 
death. 
Discussion 
Our results demonstrate that interactions  of the costimu- 
latory molecules CD28 and CTLA-4 with cells bearing B7-1 
or B7-2 mediate inhibition of glucocorticoid-induced apop- 
tosis  in  thymocytes.  We  suggest  that  thymocytes  that  do 
not  express  appropriately  responsive  CD28/CTLA-4  co- 
stimulatory molecules are deleted as part  of the maturation 
process  during  thymocyte  development.  Supporting  this 
interpretation  are  reports  that  CD28  knockout  mice  un- 
dergo  both  positive  and  negative  selection  (19).  CD28 
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Figure  5.  Expression  of CTLA-4 on thymocytes.  Profiles of thymo- 
cytes from C57BL/6 mice were generated  by triple staining thymocytes 
for the expression of CD4, CD8, and CTLA-4 as described in Materials 
and  Methods.  CTLA-4  expression  (solid  lines)  compared  with  isotype 
controls  (dashed  lines)  on: (A) DP;  (B) CD4+;  (C) CD8+; and  (D) DN, 
populations  of thymocytes. 
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Figure  6.  CD28  expression  on thymocytes.  Thymocytes were triple 
stained for CD4, CD8, and CD28 as described in Materials and Methods. 
CD28 expression was highest on CD4 +, SP thymocytes  (dashed line),  and 
expression was detected on DP thymocytes  (solid  line)  and CD8 + (dotted 
line) with some expression detected on DN thymocytes  (solid gray line). 
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CTLA-4  which  can  interact  with  B-7  bearing  APC  and 
thus  are  protected  from glucocorticoid-induced  death.  In 
contrast,  CTLA-4  knockout  mice  have  reduced  numbers 
of DP thymocytes, accumulating DN  and  CD3 +  SP cells, 
and  exhibit  massive  lymphoproliferation  resulting  in  au- 
toreactive  T  cells  (20,  21).  This  observation  can  be  ex- 
plained  by  the  acute  susceptibility  of DP  thymocytes  to 
glucocorticoids in  the  absence  of a  rescue  signal provided 
by costimulation. Without rescue, a relative decrease in the 
number  of DP thymocytes would shift  the  thymic profile 
by increasing the  proportion  of DN  thymocytes.  The re- 
maining DP population likely would be rescued by CD28 
interactions.  Interestingly,  the  CTLA-4  knockouts  were 
generated on a C57BL/6 background and, as we have indi- 
cated, rescue ofthymocytes from glucocorticoids in C57BL/6 
can  result  from  interactions  between  CD28  and  the  B7 
bearing APC. This can be interpreted to mean that survival 
in the presence  of glucocorticoids mediated  by CD28 in- 
teractions in the absence of CTLA-4-mediated interactions 
results in the preferential expansion of autoaggressive T  cells, 
which  mediate  dramatic  self-destruction  in  the  host.  The 
rescue ofT cells capable of being costimulated from "death 
by neglect" (22) provides the basis for subsequent costimu- 
latory interactions required for T  cell activation. 
T  cell activation requires  recognition of antigens  associ- 
ated with MHC-encoded molecules (23) and a second sig- 
nal provided by costimulatory interactions  (24).  Peripheral 
T  cells must express a repertoire  of TCR  capable of recog- 
nizing  any  antigen  the  T  cell  may  encounter.  Thus,  the 
TClL  preserves  the  antigen  specificity in  an  immune  re- 
sponse.  Why  then  is  costimulation  necessary?  If positive 
and negative selection in the thymus generated all possible 
T  cell receptors capable of recognizing foreign antigens and 
eliminated all self-reactive T  cells,  costimulation would not 
be required.  However, if all T  cell receptors capable of rec- 
ognizing  self antigens  were  not  removed  in  the  thymus 
(25), one would predict the necessity for a control mechanism 
to prevent self destruction. The existence of peripheral self- 
reactive T  cell receptors is well documented.  Therefore,  the 
expression  of costimulatory  molecules  on  self-tissue  must 
be tightly regulated to avoid T  cell-mediated  self destruc- 
tion. We propose that the requirement  for T  cell costimu- 
lation provides such control. That is,  the ability of a T  cell 
to be costimulated allows the T  cell to function. Therefore 
it is reasonable that a mechanism exists to insure that T  cells 
can  be  costimulated  and  this  process  likely  occurs  during 
development in the thymus. 
We  propose  that  a  mechanism which  removes,  by cell 
death,  the majority of thymocytes is provided by the pres- 
ence  of glucocorticoids in  the  thymus.  This  constitutes  a 
process  of  death  by  neglect  (22),  such  that  those  thy- 
mocytes that fail to undergo any life-promoting interaction 
in  the  thymus,  die.  Hence,  rescue  from  glucocorticoid- 
induced cell death by costimulatory interactions predictably 
would insure that thymocytes develop into T  cells  capable 
of being costimulated when responding to nonself antigens 
or damaged self antigens at sites  of inflammation. 
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